Hikma Pharmaceuticals USA Inc. Extends Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP 30mg/mL, 1mL Fill/2mL Vials Due to the Potential Presence of Small Particulates
Hikma Pharmaceuticals PLC (Hikma, Group), today announces that its subsidiary Hikma Pharmaceuticals USA Inc. (formerly known as West-Ward Pharmaceuticals Corp.; “Hikma”) is voluntarily extending its previously-announced recall of certain lots (listed below) of Ketorolac Tromethamine Injection USP 30 (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 5, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Zyla Life Sciences Announces Management Changes
WAYNE, Pa., Oct. 23, 2019 -- (Healthcare Sales & Marketing Network) -- Zyla Life Sciences (OTCQX: ZCOR) ("Zyla"), a commercial-stage life sciences company, today announced that Robert Radie, has resigned as president, chief executive officer and... Biopharmaceuticals, Personnel Zyla Life Sciences, SPRIX, ketorolac tromethamine, ZORVOLEX, VIVLODEX, meloxicam (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 23, 2019 Category: Pharmaceuticals Source Type: news

Zyla Life Sciences Appoints Dr. H. Jeffrey Wilkins as Chief Medical Officer
WAYNE, Pa., June 12, 2019 -- (Healthcare Sales & Marketing Network) -- Zyla Life Sciences (OTCQX:ZCOR) ("Zyla"), a growing commercial-stage life sciences company, announced the appointment of H. Jeffrey Wilkins, M.D. as senior vice president and... Biopharmaceuticals, Personnel Zyla Life Sciences, SPRIX, ketorolac tromethamine, ZORVOLEX, VIVLODEX, meloxicam (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 12, 2019 Category: Pharmaceuticals Source Type: news

Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
Sagent Pharmaceuticals, Inc. today announced the voluntary nationwide recall of one lot of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL). This product was manufactured by Zydus (Cadila Healthcare Limited) and distributed by Sagent Pharmaceuticals, Inc. Sagent has initiated this volun (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 3, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Ketorolac Tromethamine Injection (New - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - June 5, 2018 Category: Drugs & Pharmacology Source Type: news

Egalet Announces Large Regional Plan to Cover SPRIX(R) Nasal Spray
WAYNE, Pa., May 29, 2018 -- (Healthcare Sales & Marketing Network) -- Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for ... Biopharmaceuticals, Reimbursement Egalet Corp, SPRIX , ketorolac tromethamine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 29, 2018 Category: Pharmaceuticals Source Type: news

Ketorolac Tromethamine Injection (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - April 13, 2018 Category: Drugs & Pharmacology Source Type: news

Acuvail (Ketorolac Tromethamine Ophthalmic Solution) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 11, 2017 Category: Drugs & Pharmacology Source Type: news

Acular LS (Ketorolac Tromethamine Ophthalmic Solution) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 11, 2017 Category: Drugs & Pharmacology Source Type: news

Acular (Ketorolac Tromethamine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 11, 2017 Category: Drugs & Pharmacology Source Type: news

Toradol (Ketorolac Tromethamine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 11, 2017 Category: Drugs & Pharmacology Source Type: news

Sprix (Ketorolac Tromethamine Nasal Spray) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 9, 2016 Category: Drugs & Pharmacology Source Type: news

Ketorolac Tromethamine Injection (Updated - Resolved)
Updated Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - February 23, 2016 Category: Drugs & Pharmacology Source Type: news

Ketorolac Tromethamine Injection by Hospira: Recall - Particulate in Glass Vials
Administration of particulates has the potential for localized inflammation, allergic reaction, granuloma formation, microembolic effects, or delay of therapy. (Source: FDA MedWatch)
Source: FDA MedWatch - February 11, 2015 Category: American Health Source Type: news

Ketorolac Tromethamine Injection by Sagent Pharmaceuticals Recalled:...
On October 6, the FDA announced that three lots of Ketorolac Tromethamine Injection, USP, 30mg/mL single-dose vials, distributed by Sagent, are recalled due to incorrect labeling. In light of this...(PRWeb October 09, 2014)Read the full story at http://www.prweb.com/releases/2014/10/prweb12235068.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 9, 2014 Category: Pharmaceuticals Source Type: news

Ketorolac Tromethamine Injection, USP, 30mg/ml by Sagent Pharmaceuticals: Recall - Incorrect Labeling
The labeled expiration date is longer than the known stability of the product. (Source: FDA MedWatch)
Source: FDA MedWatch - October 6, 2014 Category: American Health Source Type: news